海泰新光涨1.05%，成交额1.43亿元，近5日主力净流入-1156.69万

Core Viewpoint - The company, Qindao Haitai New Light Technology Co., Ltd., is focused on integrating optical technology with cutting-edge applications in the medical device industry, particularly in high-performance endoscope products, and has been recognized as a "specialized, refined, distinctive, and innovative" enterprise by the Ministry of Industry and Information Technology of China [2][3]. Company Overview - Qindao Haitai New Light was established on June 11, 2003, and went public on February 26, 2021. The company specializes in the research, development, production, and sales of medical endoscope devices and optical products [7]. - The revenue composition of the company includes 64.86% from medical endoscope devices, 21.63% from optical products, 13.09% from maintenance services, and 0.42% from leasing [7]. - As of June 30, 2025, the company reported a revenue of 266 million yuan, representing a year-on-year growth of 20.50%, and a net profit attributable to shareholders of 74.44 million yuan, with a growth of 5.52% [7]. Market Performance - On September 1, the company's stock price increased by 1.05%, with a trading volume of 143 million yuan and a turnover rate of 2.70%, leading to a total market capitalization of 5.283 billion yuan [1]. - The average trading cost of the stock is 41.45 yuan, with the current price fluctuating between a resistance level of 47.08 yuan and a support level of 41.96 yuan, indicating potential for range trading [6]. Financial Analysis - The company benefits from a significant overseas revenue share, which is 69.12%, largely due to the depreciation of the Chinese yuan [3]. - The company has distributed a total of 277 million yuan in dividends since its A-share listing, with 207 million yuan distributed over the past three years [8]. Shareholder Information - As of June 30, 2025, the number of shareholders increased to 5,285, with an average of 22,682 shares held per shareholder, a decrease of 16.39% from the previous period [7].